Agustin Melian is Chief Medical Officer at Allovir, Inc. (ALVR). They have made 5 open-market trades across 1 company since 2021, most recently 2022-10-14.
CIK 0001818064
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALVR | SELL | 2021-10-04 | 2021-10-05 | $23.89 | $885K | +1.4% | +12.3% | -38.3% |
| ALVR | SELL | 2021-09-28 | 2021-09-29 | $24.12 | $90K | -8.8% | -2.9% | -46.2% |
| ALVR | SELL | 2021-04-05 | 2021-09-20 | $22.09 | $1.8M | +9.3% | +6.9% | -35.7% |
| ALVR | SELL | 2021-03-22 | 2021-03-24 | $25.97 | $195K | +5.7% | +2.5% | -6.0% |
| ALVR | SELL | 2021-02-02 | 2021-02-04 | $41.19 | $4.5M | -4.1% | -30.5% | -49.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.